Novo Nordisk flags Cagrilintide promise in hunt for next obesity drug US$ 28.21 Min. order: 1 piece ★★★★★ 4.5 (129 reviews) Sold : Login>>
CagriSema vs Tirzepatide: 23% Weight Loss in Phase 3 Trial US$ 28.84 Min. order: 1 piece ★★★★★ 5.0 (212 reviews) Sold : Login>>
Novo Nordisk's Cagrilintide shows promising weight loss in REDEFINE-1 sub-analysis, unveiled at EASD 2025 US$ 21.85 Min. order: 1 piece ★★★★★ 4.1 (157 reviews) Sold : Login>>
Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes US$ 22.07 Min. order: 1 piece ★★★★★ 4.4 (175 reviews) Sold : Login>>